The 2nd Annual World Congress Summit on Evidence Strategies to Support Pricing, Reimbursement and Market Access
To stay competitive and ensure market adoption, pharma needs market intelligence about how payers apply evidence in their value determinations about drugs, and then must apply that knowledge when planning research on products in early development, followed by HEOR initiatives and subsequent communications to demonstrate value. At this Summit, delegates have an opportunity to engage with stakeholders on what their needs are for evidence, learn how it factors into decisions on coverage policy, and recognize changes in the US reimbursement landscape that affects their overall assessment of value. Through panel discussions and case studies, delegates gain strategies for effectively generating and delivering evidence in a manner that payers, ACOs, and the new integrated delivery models favor.
Top Reasons to Attend
- Discuss payer needs for evidence and learn how it factors into formulary decision making
- Deliver a product value proposition that payers, ACOs and IDNs favor
- Align the clinical development plan with commercialization and market access strategies
- Develop pharmacoeconomic models proven to increase the payer’s understanding of economic benefits and budget impact
- Overcome payer skepticism about pharmaceutical driven evidence through a multi-stakeholder collaborative research framework
- Gain insight into expected FDA guidance on FDAMA Section 114 and its implications for communications and claims
Featured Session
The AMCP Format for Formulary Submissions – How It is Changing to Promote Better Evidence and Decisions
- Hear a manufacturer's point-of-view on dossier preparation
- Understand a health plan or PBM perspective on the application of evidence to formulary decision-making
- Analyze results from an audit and review areas identified for improvement
| Pete Penna, PharmD Principal and Co-Founder Formulary Resources, LLC |
Steven G. Avey, RPh, MS, FAMCP Vice President, Specialty Pharmacy MedImpact |
Eleonora Ford, PhD Director, Payer and Formulary Medical Information Amgen |
Who Should Attend
Pharmaceutical and Medical Device industries
- Health Economics Outcomes Research (HEOR)
- Market Access
- Payer Marketing
- Medical Affairs
- Pharmacoeconomics
- Epidemiology
Testimonials from participants of previous World Congress Pharmaceutical Events:
